Clinical trial · Interventional
Comparison of Laparoscopic Versus Open Gastrectomy for Advanced Gastric Cancer:A Prospective Randomized Trial
Prospective Randomized Trial of Laparoscopic Versus Open Gastrectomy for Advanced Gastric Cancer
NCT01043835CI-TRIAL-00007056unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to compare the short- and long-term results between the laparoscopy-assisted gastrectomy and the open gastrectomy.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Complications | — | UNRESOLVED | — |
| Gastrectomy | — | UNRESOLVED | — |
| Laparoscopy | — | UNRESOLVED | — |
| Stomach Neoplasm | Gastric Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Laparoscopy-assisted gastrectomy | Procedure | — | UNRESOLVED |
| Open gastrectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Laparoscopy-assisted gastrectomy
- interventionNames
- Procedure: Laparoscopy-assisted gastrectomy
- type
- ACTIVE_COMPARATOR
- label
- Open gastrectomy
- interventionNames
- Procedure: Open gastrectomy
Primary outcomes (1)
- measure
- Disease free survival
- timeFrame
- 3 years
Secondary outcomes (1)
- measure
- Complications, recurrence, quality of life measured by EORTC QLQ-C30 V 3.0 and EORTC QLQ-STO22
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Pathologically proven gastric adenocarcinoma 2. Age:older than 18 years old,younger than 80 years old 3. Preoperative stage(CT, GFS stage):cT2N0M0, cT2N1M0, cT2N2M0, cT3N0M0, cT3N1M0,cT3N2M0 4. ASA score:≤3 5. Patients with an invasion of the gastric serosa exceeding 10 cm2 according to ultrasound examination or examination during surgery were excluded 6. No history of other cancer 7. No history of chemotherapy or radiotherapy 8. Written informed consent Exclusion Criteria: 1. Concurrent cancer patients or patient who was treated due to other types of cancer before the patient was diagnosed as a gastric cancer patient 2. Patient who was treated by other types of treatment methods, such as chemotherapy, immunotherapy, or radiotherapy 3. Patient who was received upper abdominal surgery (except, laparoscopic cholecystectomy) 4. ASA score:\>3 5. Contraindication of laparoscopy: severe cardiac disease, abdominal wall hernias, diaphragmatic hernias, uncorrected coagulopathies, portal hypertension, pregnancy 6. Complicated case needed to get emergency operation 7. Any accompanying surgical condition needed to be performed in same time
References
Publications (0)
Data not yet available
No reference posted for this study.